Aroclor 1268

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Bradley, Patrick W: 1 article (03/2016)
2.	Fitzgerald, Scott D: 1 article (03/2016)
3.	Folland, William R: 1 article (03/2016)
4.	Fuchsman, Phyllis C: 1 article (03/2016)
5.	Kannan, Kurunthachalam: 1 article (03/2016)
6.	Kern, John: 1 article (03/2016)
7.	Newsted, John L: 1 article (03/2016)
8.	Zwiernik, Matthew J: 1 article (03/2016)
9.	Britt, Janice K: 1 article (08/2004)
10.	James, Robert C: 1 article (08/2004)

1.	Neoplasms (Cancer) 08/01/2004 - "Therefore, we suggest an upper-bound cancer potency factor of 0.27(mg/kg-day)(-1) for Aroclor 1268, a value that is 7- to 8-fold lower than the USEPA's current default, but nonetheless adequately conservative." 08/01/2004 - "We have therefore undertaken the task of developing cancer potency estimates specifically for Aroclor 1268. " 08/01/2004 - "Rodent cancer bioassays indicate that substantial differences exist among PCB mixtures in terms of tumorigenic response, although no bioassay has been conducted with Aroclor 1268. "
2.	Mouth Neoplasms (Oral Cancer) 08/01/2004 - "Development of an oral cancer slope factor for Aroclor 1268."
3.	Hypothyroidism 03/01/2016 - "Anemia, hypothyroidism, and hepatomegaly were observed in mink exposed to Aroclor 1268 beyond various dietary thresholds. "
4.	Hepatomegaly 03/01/2016 - "Anemia, hypothyroidism, and hepatomegaly were observed in mink exposed to Aroclor 1268 beyond various dietary thresholds. "
5.	Body Weight (Weight, Body) 05/01/1989 - "PCB compounds decreased body weights but did not affect organ weights of goats except for a liver weight increase at 20 mg/kg for 2,4-DCBP, Aroclor 1268 and PCT. "

1.	2,4-diamino-5-cyano-6-bromopyridine